Physicians’ Acceptance of Pharmacists’ Intervention In Type 2 Diabetes Mellitus Patients Attending Three Secondary Care Facilities, Ilorin

BACKGROUND: Clinical pharmacists review medication orders from prescribers to prevent drug-related problems (DRPs). AIM: To assess physician acceptance rate of pharmacist’s intervention in type 2 diabetes mellitus patients attending three secondary care facilities. METHOD: This study was a cross-sectional study among out-patients with Type 2 Diabetes mellitus attending three secondary care facilities. Study was carried out between the months of September 2023 to October 2023. For categorical measurements the frequencies was computed. Data was analyzed using the SPSS version 25. The result was expressed in descriptive statistics using chi-square test. P-value < 0.05 was considered as statistically significant. RESULTS: Of the respondents 61.6% (85) were female while 38.4% (53) were male. Age range of 60-69 had the highest response (41, 29.7%). Overall physician acceptance rate of pharmacist’s interventions was 100.0%. The most common interventions accepted by physicians include addition of statins to respondent’s medications due to moderate to high cardiovascular disease risk score, need to monitor lipid profile, and institution of adherence program. CONCLUSION: Overall physician acceptance rate of pharmacist’s interventions was 100.0%.